![Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update](https://www.frontiersin.org/files/Articles/1022530/fgstr-01-1022530-HTML-r1/image_m/fgstr-01-1022530-g001.jpg)
Frontiers | Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update
![Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy - European Medical Journal Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2017/05/Figure-3-ECCO-Guidelines-2016-for....jpg)
Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy - European Medical Journal
![The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-25218-x/MediaObjects/41598_2022_25218_Fig1_HTML.png)
The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports
![European Crohn´s and Colitis Organisation - ECCO - P477 Assessment of treatment sequence and real-world outcomes in patients with Ulcerative Colitis European Crohn´s and Colitis Organisation - ECCO - P477 Assessment of treatment sequence and real-world outcomes in patients with Ulcerative Colitis](https://cm.ecco-ibd.eu/cmAbstractSubmission/Content/cmabstsms/EC21/abstracts/0000000270/0000806820/Images/TKEP014-ZPD678KTFig01.png)
European Crohn´s and Colitis Organisation - ECCO - P477 Assessment of treatment sequence and real-world outcomes in patients with Ulcerative Colitis
![Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut](https://gut.bmj.com/content/gutjnl/70/6/1044/F1.large.jpg)
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut
![Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study](https://www.frontiersin.org/files/Articles/851295/fpubh-10-851295-HTML-r1/image_m/fpubh-10-851295-g001.jpg)
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
![Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1873994614001482-gr2.jpg)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect
![European Crohn´s and Colitis Organisation - ECCO - Evolving Treatment Options for Patients with Ulcerative Colitis (UC) European Crohn´s and Colitis Organisation - ECCO - Evolving Treatment Options for Patients with Ulcerative Colitis (UC)](https://www.ecco-ibd.eu/images/Screenshot_47.png)
European Crohn´s and Colitis Organisation - ECCO - Evolving Treatment Options for Patients with Ulcerative Colitis (UC)
![JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis](https://www.mdpi.com/jcm/jcm-11-02302/article_deploy/html/images/jcm-11-02302-g001-550.jpg)
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
![European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies](https://www.ecco-ibd.eu/images/6_Publication/6_2_ECCO_News/ECCO_News_Images/2021_Issue_3/Nestle/Graphic%203_ECCO.png)
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
![Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies - Calméjane - United European Gastroenterology Journal - Wiley Online Library Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies - Calméjane - United European Gastroenterology Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aa901e5f-3fde-4abd-ad52-eae9a2654f46/ueg212442-toc-0001-m.jpg)
Review article: Updated management of acute severe ulcerative colitis: From steroids to novel medical strategies - Calméjane - United European Gastroenterology Journal - Wiley Online Library
![British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut](https://gut.bmj.com/content/gutjnl/68/Suppl_3/s1/F2.large.jpg)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut
![First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrgastro.2013.31/MediaObjects/41575_2013_Article_BFnrgastro201331_Fig1_HTML.jpg)
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents? | Nature Reviews Gastroenterology & Hepatology
![Figure 2 from Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. | Semantic Scholar Figure 2 from Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9177b4ea36dc064d0157292a81e7740800f0890a/20-Figure2-1.png)